Zhongxing BioTech: Net profit in the first half of the year is expected to increase by 86.57%-137.46% year-on-year

Zhongxing BioTech released its performance forecast for the first half of 2025, expecting a net profit attributable to shareholders of the listed company to be between 55 million and 70 million yuan, an increase of 86.57% to 137.46% compared to the same period last year. During the reporting period, the sales price of Agaricus bisporus products remained stable with an upward trend, and the operating performance of individual products increased year-on-year; investment income from joint ventures increased year-on-year; investment income from financial products and changes in fair value gains and losses increased by approximately 8 million yuan year-on-year; financial expenses decreased year-on-year